Lindbrook Capital, LLC - ITEOS THERAPEUTICS INC ownership

ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 120 filers reported holding ITEOS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of ITEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,672
+162.2%
244
+216.9%
0.00%
Q2 2023$1,019
+211.6%
77
+220.8%
0.00%
Q1 2023$327
-78.0%
24
-68.4%
0.00%
Q4 2022$1,484760.00%
Q3 2022$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q2 2022$19,000
-36.7%
9300.0%0.00%
-40.0%
Q1 2022$30,000
-30.2%
9300.0%0.01%
-28.6%
Q4 2021$43,000
+65.4%
930
-7.0%
0.01%
+16.7%
Q2 2021$26,0001,0000.01%
Other shareholders
ITEOS THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,738,785$52,174,00019.87%
MPM BioImpact LLC 1,745,943$33,260,0007.88%
Boxer Capital, LLC 2,154,058$41,035,0002.31%
TANG CAPITAL MANAGEMENT LLC 937,500$17,859,0002.19%
RA Capital Management 4,417,259$84,149,0001.80%
BVF INC/IL 1,810,835$34,496,0001.42%
Zebra Capital Management LLC 12,271$234,0000.89%
Integral Health Asset Management, LLC 195,000$3,715,0000.72%
Prairiewood Capital, LLC 32,269$615,0000.51%
DAFNA Capital Management LLC 97,560$1,859,0000.50%
View complete list of ITEOS THERAPEUTICS INC shareholders